Hokkaido University · Faculty of Medicine / Graduate School of Medicine / Medical Research Institute · 助教

Research keywordsurothelial carcinoma immunotherapy・bladder cancer stem cells・metastatic renal cell carcinoma・cytoreductive nephrectomy・prostate cancer survivorship・laparoscopic surgical training

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Decision regret after curative treatment and its association with the decision-making process and quality of life for prostate cancer patients.2025 · International journal of urology : official journal of the Japanese Urological Association, 32, 1, 95, 102, 2025年01月,
• Cisplatin resistance driver claspin is a target for immunotherapy in urothelial carcinoma.2023 · Cancer immunology, immunotherapy : CII, 2023年02月16日,
• Think different in metastatic RCC treatment 免疫チェックポイント阻害薬時代におけるCytoreductive nephrectomy(CN)の意義2023 · 泌尿器外科, 36, 臨増, 788, 789, 医学図書出版(株), 2023年08月
• GRIK2 is a target for bladder cancer stem-like cell-targeting immunotherapy.2022 · Cancer immunology, immunotherapy : CII, 71, 4, 795, 806, 2022年04月,

• 膀胱癌幹細胞様細胞を標的とする免疫療法と化学・放射線療法との相乗効果の解明

• Official profile